| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |